Clinical trials for Q Fever

Information provided by WHO International Clinical Trials Registry

The clinical trials below are relevant to Q Fever. For all clinical trials, go to clinical trials search

This list shows clinical trials for Q Fever

Search result filters
Recruitment status
Trials for children:
Country of trial:

You have searched for the following terms

  • Q Fever
Title Recruitment status Location
A clinical trial to study the safety, efficacy and tolerability of the drug Ceftazidime-Avibactam(CAZ-AVI) versus Meropenem in patients with Nosocomial Pneumonia(NP) including Ventilator Associated Pneumonia(VAP). Recruiting United Kingdom
Management of heart muscle injury following a non cardiac surgery to prevent death, heart attack and stroke. Recruiting United Kingdom
Clinical study to find out whether regular infusions of ADVATE in the absence of immunological danger signals (eg. tissue damage/viral or bacterial infections) reduces the possibility of inhibitor in PUPs with hemophilia A Not Recruiting United Kingdom
An open-label extension study of canakinumab (ACZ885) in patients with Systemic Juvenile Idiopathic Arthritis (SJIA) and active systemic manifestations who participated in studies ACZ885G2301 and ACZ885G2305;and response characterization study in canakinumab treatment-naïve patients with active SJIA with and without fever - G2301E1 Not Recruiting United Kingdom
Clinical study to find out whether regular infusions of ADVATE in the absence of immunological danger signals (eg. tissue damage/viral or bacterial infections) reduces the possibility of inhibitor in PUPs with hemophilia A Not Recruiting United Kingdom
Clinical study to find out whether regular infusions of ADVATE in the absence of immunological danger signals (eg. tissue damage/viral or bacterial infections) reduces the possibility of inhibitor in PUPs with hemophilia A Not Recruiting United Kingdom
A Multicenter, Open-Label, Ascending Multiple-Dose Study to Assess the Pharmacokinetics, Safety, and Tolerability of Tigecycline in Patients 8 to 11 Years of Age With Selected Serious Infections Not Recruiting United Kingdom
An open-label, phase II dose titration study of ACZ885 (human anti-IL-1beta monoclonal antibody) to assess the clinical efficacy, safety, pharmacokinetics and pharmacodynamics in patients with NALP3 mutations - A2102 Not Recruiting United Kingdom
The effect of tocilizumab in children who have arthritis which can include fever, rash, inflammation of the lungs or heart, or enlarged spleen, liver or lymph nodes. Not Recruiting United Kingdom
Clinical study to find out whether regular infusions of ADVATE in the absence of immunological danger signals (eg. tissue damage/viral or bacterial infections) reduces the possibility of inhibitor in PUPs with hemophilia A Not Recruiting United Kingdom

Page last reviewed: 09/02/2015

Next review due: 01/02/2018